Murphy's analysis
$Pfizer (PFE.US)$ Following the prediction and strategy on February 2, in the subsequent market progress, the price did not hit the level of 26.2+, but started to rebound at 26.52! However, this one percent error is clearly not luck, but a mistake! Looking back at the 30-minute chart on 12/15/2023, 26.58 was the upper limit of the central range on the 30-minute chart from 12/13 to 12/15, while Murphy actually took 26.23 in actual trading, which is the axis of that range! The trend must be perfect! It is inevitable that there will be the first rebound on the 30-minute level beyond the current upper limit of the range, and then determine in the subsequent trend whether it will extend upwards or consolidate downwards! The upper limit of the consolidating range downwards then serves as a secondary replenishment point, while the axis at 26.23 is the optimal intraday trading point and even a position for adding to positions in swing trading; this depends on individual style and strategy to choose between day trading or swing trading! Missing 26.52 is, of course, not waiting around, but acting with the trend. The level of 27.50 is the axis of the daily chart, and 28.02 is the highest point of the rebound from 26.52, thus establishing the selling range of 27.50 to 28.02! Within this range, Murphy first executed a trade at 27.53, of course, this position was not very precise, overslept and luckily was awakened by a call from a buddy to place a trade with groggy eyes, because without monitoring, couldn't hit the intraday high point, so immediately placed an order at 27.20 for replenishment hoping to make back the difference of not selling near the high point with a low point replenishment trade within the day, but on February 6th, even that day...
The above are personal opinions and trading notes, not investment advice! Buying and selling at your own discretion, profits and losses are your own responsibility!
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
